Description: Stevanato Group S.p.A. engages in the design, production, and distribution of products and systems to provide integrated solutions for pharma and healthcare. Its principal products are linked to containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machine. Stevanato Group S.p.A. was founded in 1949 and is based in Piombino Dese, Italy.
Home Page: www.stevanatogroup.com
STVN Technical Analysis
Via Molinella, 17
Piombino Dese,
PD
35017
Italy
Phone:
39 04 99 31 811
Officers
| Name | Title |
|---|---|
| Mr. Franco Stevanato | Exec. Chairman |
| Mr. Franco Moro | CEO, COO & Director |
| Mr. Marco Dal Lago | Chief Financial Officer |
| Mr. Paolo Patri | Chief Technology Officer |
| Ms. Lisa Miles | Sr. VP of Investor Relations |
| Mr. Mauro Stocchi | Chief Bus. Officer |
| Mr. Riccardo Butta | Pres of Americas |
Exchange: NYSE
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 30.2115 |
|---|---|
| Trailing PE: | 39.9406 |
| Price-to-Book MRQ: | 4.3546 |
| Price-to-Sales TTM: | 5.0554 |
| IPO Date: | 2021-07-16 |
| Fiscal Year End: | December |
| Full Time Employees: | 4652 |